6.32
Boston Scientific Corp.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
5.76
FY23:
6.51
FY24:
6.92
FY25:
8.79
(positive)
Change from FY21 to FY25
billions USD
FY21:
25.9
FY22:
26.7
FY23:
28.6
FY24:
32.5
FY25:
34.9
Total assets
Change from FY21 to FY25
billions USD
FY21:
32.2
FY22:
32.5
FY23:
35.1
FY24:
39.4
FY25:
43.7
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
4.27
FY22:
3.80
FY23:
4.93
FY24:
6.40
FY25:
5.44
(positive)
Change from FY21 to FY25
billions USD
FY21:
16.6
FY22:
17.6
FY23:
19.3
FY24:
21.8
FY25:
24.2
All amounts in billions USD